Discover
Visualize rapid, validated insights through real-world data.
Psychiatrist and health care CEO Dr. Gary Gottlieb: Treating the patient as a whole person
With his previous professional experience ranging from CEO of Massachusetts-based ...
Aetion, Dr. Scott Gottlieb, biopharma leaders’ discussions at JPM 2020: It’s time to “knock on an open door” to further RWE standards and acceptance
This January, in the whirlwind week of the 36th Annual J.P. Morgan Healthcare Conference ...
How to amplify RWE clarity and reproducibility with data visualizations: Q&A with Dr. Shirley Wang of the REPEAT initiative
While analyses of non-randomized health care databases—insurance claims, electronic ...
Artificial Intelligence in Health Care - GAO Report
Benefits and Challenges of Machine Learning in Drug Development The adoption of ...
Ten Things I Have Learned About Health Data Monetization
Khaled El Emam, SVP & GM, Replica Analytics
Why diverse data teams lead to bigger wins, and other perspectives from retail tech: A Q&A with Stitch Fix CTO, Cathy Polinsky
Cathy Polinsky’s deep love of programming, problem-solving, and perfecting client ...
How emerging technologies will ensure increasing availability of RWD
The potential of real-world data (RWD) to transform clinical trials is drawing attention ...
Contextual considerations in RWE generation and use
There’s a lot of buzz around the potential impact of real-world evidence (RWE) in health ...
The shift from health technology assessment to management: What is RWE’s role?
As innovation in health care advances—and the associated costs escalate—payers are ...
Ten Things I Have Learned About De-identification
RWE use by HTAs: How has it evolved, and where is it headed next? Q&A with Dr. Jens Grueger
Health technology assessment (HTA) agencies are increasingly turning to real-world ...
Tutorials | What is Synthetic Data ?
A general introduction and overview of synthetic data and its uses.
Tutorials | Managing Identity Disclosure
An overview of the key privacy risks that data synthesis is meant to manage.
Tutorials | When to Synthesize
Making a case for using and getting value from synthetic data.
RWE and the value equation: U.S. health care purchaser perspectives on payment model evolution and the role of RWE
Much discussion surrounds rising drug prices—and the numerous parties affected. ...
Tutorials | Privacy Law & Synthetic Data
International trends in privacy law relating to synthetic data.*
Tutorials | How Good is Synthetic Data ?
Defining and assessing the “goodness” of synthetic data
Tutorials | Enabling AI
Using data synthesis to enable Artificial Intelligence.
Let’s talk about value: How biopharma can maximize utility of RWE in value discussions
With the drug pricing pressures mounting on a global scale, there is a clear and imminent ...
Ask our experts: Working with real world data sets: What types of questions can your data answer?
The promise of real-world evidence (RWE) comes with a steep learning curve. As regulators ...
Managing the Risks from AI Algorithms
In the webinar organized by Replica Analytics in November 2019 entitled "Managing the ...
Advancing cancer care with real-world data: Next steps for collaborators
In oncology, over 90 percent of patient treatment experiences occur outside of clinical ...
Evidence at the Apex: Five learnings from the first annual Aetion Summit
Last month, the inaugural Aetion Summit in New York City brought together some of the ...
Learnings from three FDA decisions on ECA submissions in oncology
The publication of the Framework for FDA’s Real-World Evidence Program nearly a year ago ...